HHS convenes experts to define standards for clinical AI

Source: STAT News — 2026-07-23

Summary

The White House's Office of Science and Technology Policy, the FDA, and the Office of the National Coordinator for Health Information Technology are jointly convening outside experts to hash out what counts as "safe and effective" clinical AI as tools move from research settings into live hospital use. The effort is structured as a one-month "sprint" with a written-comment phase followed by a discussion phase, aimed at producing a consensus set of principles rather than binding rules — a first step toward formal federal standards for medical AI.

Key Takeaways

• Multi-agency convening (OSTP, FDA, ONC) is seeking consensus among outside experts on standards for "explainable AI" (XAI) in clinical settings, so health tech vendors can provide a clear audit trail for AI-driven decisions.
• The process is structured as a one-month sprint: a written-input phase followed by a discussion phase, rather than an open-ended rulemaking process.
• A central concern is that clinical AI often functions as a "black box" — the path from input data to a clinical recommendation isn't transparent to the treating physician, which the convening frames as a patient-safety risk.
• The panel is also expected to address mandating diversity in training data and implementing continuous, real-time auditing for bias in deployed clinical AI systems.
• This convening follows HHS's broader push on AI adoption in clinical care, including its December 2025 Request for Information on accelerating AI use in clinical settings — signaling the agency is moving from information-gathering toward defining actual evaluation standards.

Discussion

(No questions yet — ask follow-ups via a Claude Code chat session on this repo; answers get appended here.)